Haisco Pharmaceutical Group Co., Ltd.

This study tests a new tablet called HSK44459 for people with progressive pulmonary fibrosis, a condition where lung scarring worsens over time. The trial will include 378 adults and measure changes in lung function after one year. Participants may or may not be taking other anti…

This study tests a new tablet called HSK44459 for people with idiopathic pulmonary fibrosis (IPF), a disease that causes lung scarring and makes breathing hard. About 420 adults aged 40 and older will take either the drug or a placebo for a year. The main goal is to see if the dr…

This study tests a new medicine called HSK31679 for people with MASH, a serious liver condition linked to metabolic issues. About 400 adults will receive either the drug or a placebo for 52 weeks to see if it safely reduces liver fat. The goal is to find a treatment that controls…

This study tests an experimental oral drug called HSK44459 for adults with moderate to severe plaque psoriasis. About 150 participants will receive either the drug or a placebo to see if it can reduce skin symptoms by at least 75% after 16 weeks. The goal is to find a new treatme…

This study tests a new inhaled powder called HSK39004 for people with chronic obstructive pulmonary disease (COPD). About 376 adults aged 40 to 80 will use the inhaler or a placebo for 12 weeks to see if it improves lung function. The goal is to control the disease and make breat…

This study is testing a new inhaled medication (HSK39004) for people with moderate-to-severe chronic obstructive pulmonary disease (COPD). About 300 adults aged 40 to 80 will take the drug twice daily for 52 weeks to see if it is safe and helps control their condition. The goal i…

This study tests a new drug called cofrogliptin against an older drug, acarbose, in 200 adults with type 2 diabetes who have never taken diabetes medication. The goal is to see which drug better controls blood sugar and has fewer side effects. Participants will take one of the tw…

This study tests a new anesthesia drug called cipepofol in 400 children aged 3-17 who need surgery. The goal is to see if it works as well as the standard drug propofol for putting kids to sleep, but with less pain at the injection site. Researchers will also monitor safety and h…

This study tests a new medicine called HSK55718 to see if it can safely reduce pain after orthopedic surgery. About 200 adults having bone surgery under general anesthesia will receive either HSK55718, morphine, or a placebo. Researchers will measure pain levels and how much extr…

This study tests a new medicine called HSK55718 to see if it can safely reduce pain after abdominal surgery. About 200 adults will receive either the new drug, a common painkiller (morphine), or a placebo. The goal is to find better ways to manage post-surgery pain.

This study tests an experimental drug called HSK47388 in 220 adults with moderate-to-severe plaque psoriasis. Participants will receive either the drug or a placebo for 16 weeks to see if it reduces skin redness, thickness, and scaling. The goal is to find a new treatment option …

This early-stage study tests a new drug called HSK56630 for the first time in humans. About 40 healthy adults will receive either a single dose of the drug or a placebo to check for side effects and how the drug moves through the body. The goal is to see if it is safe enough for …